1. Product Overview & Global GMP Compliance Standards
Our tailor-engineered bioreactor platform is purpose-built for iterative mammalian cell culture process optimization, covering lab-scale screening, pilot fed-batch/perfusion cultivation and scaled-up clinical manufacturing. Every platform complies fully with FDA cGMP, EMA Annex 1, PIC/S and ICH Q8/Q9/Q10 data integrity requirements, designed exclusively for monoclonal antibodies, recombinant proteins, viral vectors and cell therapeutic raw materials. Distinct from standardized fixed-spec bioreactors lacking adjustability, this modular customizable platform supports flexible structural, control and functional reconfiguration to match unique cell strain metabolic traits, resolving core pain points including insufficient shear control, limited aeration adjustability, rigid feeding logic and poor scalability during process development. It delivers audit-ready, reproducible culture environments for biotech R&D labs, CMO pilot workshops and commercial biomanufacturing production lines.
2. Core Design Philosophy & Cell Culture Optimization Advantages
Built on risk-based cell viability protection and process-deterministic optimization logic, the platform’s design prioritizes precise regulation of all cell culture critical process parameters (CPPs) to stabilize target product critical quality attributes (CQAs). The low-shear impeller system, modular sparger combinations and independent multi-loop DO/pH/temperature closed-loop control allow researchers to rapidly test variable culture strategies for titer elevation, viability extension and impurity reduction. Full-process FMEA risk control is embedded into the platform’s sanitary construction, featuring Ra ≤0.6 μm mirror polished 316L stainless steel inner surfaces, dead-angle-free piping and fully integrated CIP/SIP sterilization modules to eliminate cross-contamination and biofilm interference during repeated optimization trials. Compared with universal bioreactor equipment, the customizable platform drastically shortens process screening cycles, improves batch repeatability and delivers measurable improvements in cell density, culture duration and final product yield.
3. Four Customizable Core Platform Modules & Standard Configurations
The integrated cell culture bioreactor platform is composed of four synergistic reconfigurable functional modules, fully adaptable to all optimization workflows: modular vessel & mixing system, intelligent multi-channel feeding & aeration unit, real-time multi-parameter monitoring module, and automated control & data recording system.
The vessel & mixing module supports customizable working volumes ranging from 5 L lab screening to 5,000 L pilot scale, with interchangeable low-shear marine, pitched-blade and hydrofoil impellers for strain-specific shear optimization.
The feeding & aeration module enables independent tuning of constant-rate feeding, pulse feeding and multi-stage nutrient supplementation, paired with interchangeable micro/macro spargers to balance oxygen transfer and foam suppression.
The monitoring module expands freely with online sensors for glucose, lactate, ammonia, viable cell density and redox potential to capture full datasets for process analysis.
The control system adopts configurable PLC/HMI architecture with electronic batch recording functions, generating complete traceable data archives that meet global regulatory audit demands.
4. Industrial Application & Full Lifecycle Technical Support
This custom cell culture bioreactor platform is widely deployed for pre-clinical process screening, high-titer fed-batch/perfusion process optimization, existing production line yield upgrading and novel biotherapeutic cell strain development projects. The standardized modular architecture achieves seamless linear scale-up from lab optimization runs to commercial production without radical process rework, preserving optimized culture parameters at every volume tier. We provide full lifecycle supporting services including pre-sales process matching customization, factory FAT/SAT testing, on-site installation and commissioning, operator optimization training and long-term spare parts supply. By offering flexible, adjustable hardware dedicated to cell culture process refinement, the platform empowers biopharma clients to streamline R&D workflows, cut raw material trial costs and accelerate the industrial translation of high-yield cell culture processes.
